Search
for
Sort by
Research 30 of 539
- GLI2 Is Expressed in Normal Human Epidermis and BCC and Induces GLI1 Expression by Binding to its Promoter
- DMBA/TPA Treatment Is Necessary for BCC Formation from Patched Deficient Epidermal Cells in Ptch flox/flox CD4Cre +/− Mice
- 139 Anti-BCC efficacy of a topical hedgehog inhibitor without adverse effects in BCNS patients in a phase 2 randomized controlled trial
- 268 Use of ultra-fast one-step CK5 ihc for identifying bcc and scc during mohs surgery
- A Monoclonal Antibody Established from the Immunization of Basal Cell Carcinoma (BCC) Tissues Reacts to the Intercellular Space of BCC and Hair Follicles
- Identification of the cell lineage at the origin of basal cell carcinoma
- Tracing the cellular origin of cancer
- Hedgehog signalling in skin development and cancer
- Basal cell carcinomas in mice arise from hair follicle stem cells and multiple epithelial progenitor populations
- Patched1 Functions as a Gatekeeper by Promoting Cell Cycle Progression
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
- Basal cell carcinoma possibly originates from the outer root sheath and/or the bulge region of the vellus hair follicle
- A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy
- An in vivo comparative study of sonic, desert and Indian hedgehog reveals that hedgehog pathway activity regulates epidermal stem cell homeostasis
- Epidemiology of skin cancer in the mature patient
- YAP and TAZ are essential for basal and squamous cell carcinoma initiation
- Roles of the Hedgehog Signaling Pathway in Epidermal and Hair Follicle Development, Homeostasis, and Cancer
- Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/– mice
- Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/– mice
- Targeting Superficial or Nodular Basal Cell Carcinoma with Topically Formulated Small Molecule Inhibitor of Smoothened
- AP-1 and TGFß cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinoma
- Analysis of 1,25-Dihydroxyvitamin D3 Receptors (VDR. in Basal Cell Carcinomas
- GLI2-specific Transcriptional Activation of the Bone Morphogenetic Protein/Activin Antagonist Follistatin in Human Epidermal Cells
- Nevus comedonicus syndrome: a case associated with multiple basal cell carcinomas and a rudimentary toe
- Distinct transcriptomic landscapes of cutaneous basal cell carcinomas and squamous cell carcinomas
- Skin disorders in elderly subjects
- Field Cancerization: From Molecular Basis to Selective Field-Directed Management of Actinic Keratosis
- A Review of Hedgehog Inhibitors Sonidegib and Vismodegib for Treatment of Advanced Basal Cell Carcinoma
- Genome-wide association study of skin complex diseases